These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24599011)

  • 1. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
    Hasan AU; Ohmori K; Hashimoto T; Kamitori K; Yamaguchi F; Ishihara Y; Ishihara N; Noma T; Tokuda M; Kohno M
    Hypertens Res; 2014 Jul; 37(7):621-8. PubMed ID: 24599011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.
    Iwashita M; Sakoda H; Kushiyama A; Fujishiro M; Ohno H; Nakatsu Y; Fukushima T; Kumamoto S; Tsuchiya Y; Kikuchi T; Kurihara H; Akazawa H; Komuro I; Kamata H; Nishimura F; Asano T
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E286-96. PubMed ID: 22045314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB.
    Skurk T; van Harmelen V; Hauner H
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1199-203. PubMed ID: 15130920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
    Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
    Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
    Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system.
    Saiki A; Koide N; Watanabe F; Murano T; Miyashita Y; Shirai K
    Metabolism; 2008 Aug; 57(8):1093-100. PubMed ID: 18640387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice.
    Ushijima K; Takuma M; Ando H; Ishikawa-Kobayashi E; Nozawa M; Maekawa T; Shiga T; Fujimura A
    Eur J Pharmacol; 2013 Jan; 698(1-3):505-10. PubMed ID: 23195328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes.
    Matsushita K; Wu Y; Okamoto Y; Pratt RE; Dzau VJ
    Hypertension; 2006 Dec; 48(6):1095-102. PubMed ID: 17060512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclolepis genistoides D. Don (palo azul) promotes differentiation of adipocytes and regulates adipokine expression.
    Sato H; Ishikawa M; Funaki A; Kimura Y; Yoshida H; Fukata H; Hasegawa H; Ueno K
    Nutr Res; 2013 Nov; 33(11):922-31. PubMed ID: 24176232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.
    Hung WW; Hsieh TJ; Lin T; Chou PC; Hsiao PJ; Lin KD; Shin SJ
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):3-12. PubMed ID: 21161354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.
    Cole BK; Keller SR; Wu R; Carter JD; Nadler JL; Nunemaker CS
    Hypertension; 2010 Mar; 55(3):715-21. PubMed ID: 20100990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin inhibition stimulates PPARgamma and the release of visfatin.
    Storka A; Vojtassakova E; Mueller M; Kapiotis S; Haider DG; Jungbauer A; Wolzt M
    Eur J Clin Invest; 2008 Nov; 38(11):820-6. PubMed ID: 19021699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
    Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
    Mori Y; Itoh Y; Tajima N
    Am J Hypertens; 2007 Apr; 20(4):431-6. PubMed ID: 17386352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
    Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
    Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular effects of azilsartan: a new generation angiotensin II receptor blocker.
    Kajiya T; Ho C; Wang J; Vilardi R; Kurtz TW
    J Hypertens; 2011 Dec; 29(12):2476-83. PubMed ID: 21986624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.
    Cao Z; Kelly DJ; Cox A; Casley D; Forbes JM; Martinello P; Dean R; Gilbert RE; Cooper ME
    Kidney Int; 2000 Dec; 58(6):2437-51. PubMed ID: 11115077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects.
    Fujino M; Miura S; Kiya Y; Tominaga Y; Matsuo Y; Karnik SS; Saku K
    Hypertens Res; 2010 Oct; 33(10):1044-52. PubMed ID: 20668453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV protease inhibitors activate the adipocyte renin angiotensin system.
    Boccara F; Auclair M; Cohen A; Lefèvre C; Prot M; Bastard JP; Capeau J; Caron-Debarle M
    Antivir Ther; 2010; 15(3):363-75. PubMed ID: 20516556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.